| __timestamp | Bausch Health Companies Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2254600000 | 56369000000 |
| Thursday, January 1, 2015 | 2645000000 | 62786000000 |
| Friday, January 1, 2016 | 2611000000 | 62427000000 |
| Sunday, January 1, 2017 | 2548000000 | 62453000000 |
| Monday, January 1, 2018 | 2351000000 | 65724000000 |
| Tuesday, January 1, 2019 | 2350000000 | 70421000000 |
| Wednesday, January 1, 2020 | 2249000000 | 80591000000 |
| Friday, January 1, 2021 | 2394000000 | 86645000000 |
| Saturday, January 1, 2022 | 2364000000 | 100551000000 |
| Sunday, January 1, 2023 | 2559000000 | 42907000000 |
| Monday, January 1, 2024 | 115557000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Dr. Reddy's Laboratories Limited and Bausch Health Companies Inc. offer a fascinating comparison. From 2014 to 2023, Dr. Reddy's Laboratories consistently reported higher costs of revenue, peaking in 2024 with a staggering 115% increase from 2014. In contrast, Bausch Health's costs remained relatively stable, with a modest 13% fluctuation over the same period. This disparity highlights Dr. Reddy's aggressive expansion and investment strategies, while Bausch Health maintained a more conservative approach. Notably, 2023 saw a significant dip in Dr. Reddy's costs, possibly indicating strategic shifts or market challenges. Missing data for 2024 in Bausch Health's records suggests potential reporting delays or strategic changes. This comparison underscores the diverse strategies within the pharmaceutical sector, offering insights into how companies navigate financial landscapes.
Cost Insights: Breaking Down Neurocrine Biosciences, Inc. and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Grifols, S.A.
Dr. Reddy's Laboratories Limited vs CRISPR Therapeutics AG: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Galapagos NV
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Cost Insights: Breaking Down Bausch Health Companies Inc. and Vericel Corporation's Expenses
Comparing Cost of Revenue Efficiency: Bausch Health Companies Inc. vs Mesoblast Limited